1. The Setup — GE's transformation story, the impressive fundamentals, and the 37-analyst consensus 2. DCF — OVERVALUED, $109 vs $302, with honest discussion of assumptions and the MEDIUM confidence limitation 3. Peer Comparison — PREMIUM at 73rd percentile, P/FCF at 100th percentile, with the full 6-company table 4. The Dissent — Perplexity/Wall Street BUY case presented fairly with its own data card 5. Understanding the Disagreement — The core analytical argument: DCF asks "what is it worth?" vs analysts ask "what will others pay?" — framed as two valid but different questions 6. The Number the Street Ignores — ROE vs ROIC deep-dive (45.9% vs 8.6%), explaining leverage effects 7. The Cyclical Question — Pro-cyclical commercial aviation at 43x FCF vs counter-cyclical defense peers at lower multiples 8. Takeaway — "Great business ≠ good investment at this price. Know which game you're playing." 9. Methodology — Transparent about data sources, limitations (missing Occam score), and the educational disclaimer

Professor Okun was my finance teacher at NYU. Before NYU, he was responsible for managing IBM's pension fund where he beat the averages for many years The Private Equity Clog Has Arrived: The Big Point By rabidcapitalist on March 16, 2026 Professor Glenn A. Okun The Rabid Capitalist: The Big Point is a brief summary of a detailed note available to paid subscribers. In August 2023, the Rabid Capitalist noted that private equity’s pain would become private credit’s gain (see https://therabidcapitalist.com/2023/08/06/the-business-development-company-bdc-investment-strategy-2/). Recently, Bain reported the depth of these conditions. Our BDC portfolio (ARCC, CCAP, CSWC, FSK, MAIN, OBDC, and OCSL) is well-positioned to profit from this misery, despite AI-driven headwinds, both real and imagined. Complete content is available for a $15 monthly subscription. Click here to subscribe: Subscribe

Hello Dwayne, You should be receiving an invite to our slack channels for #Occam-The-Architect, #Occam-the-sentinel and #Occam-the-story teller to see the AI opinions for elite/healthy companies and Zombies. Best, JG Lets follow the cash together.

🎉 START HERE Welcome! I'm so glad you're here and really hope that we can build wealth together. This is a space for people who are interested in investing but may believe they don't have the skills or desire to dig into Excel spreadsheets or build discounted cash-flow valuations on the journey to achieving generational wealth. Here's how to get started: 👉 Step 1: Watch the welcome video below 👉 Step 2: Explore the classroom: You'll find [WHAT'S INSIDE] 👉 Step 3: Jump into the community and share your name and where you are located, read what others are sharing, and connect 👉 Step 4: Check out the support options Introduce yourself below! Tell us why you are interested in building wealth and what your experience is with discounted cash-flow valuation and Excel spreadsheets. Neither of which you will need with the Occam's Investing system. I'll go first: I am John Gillespie, located in Palm Coast, FL. While I have done Discounted Cash-Flow valuations, I don't find them valuable and didn't use them on my way to achieving 1,600% returns over the past 13 years. Can't wait to walk this path with you! Johnny G [] - where we apply Occam's Razor to cut through Wall Street narratives and follow the cash flow truth. This is your society of evidence-based investors who verify, don't trust. 💰 Following is an introduction to Occam's Investing https://youtu.be/o3WUAfDJx7w&views

I remember when working for my MBA and doing DCF analysis by hand, one report would take hours for the complete analysis. It is no wonder companies with analysts often only update reports periodically. The time lapse could be catastrophic for your portfolio.